Details for New Drug Application (NDA): 202803
✉ Email this page to a colleague
The generic ingredient in SUMATRIPTAN AND NAPROXEN SODIUM is naproxen sodium; sumatriptan succinate. There are forty-two drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the naproxen sodium; sumatriptan succinate profile page.
Summary for 202803
Tradename: | SUMATRIPTAN AND NAPROXEN SODIUM |
Applicant: | Sun Pharm |
Ingredient: | naproxen sodium; sumatriptan succinate |
Patents: | 0 |
Suppliers and Packaging for NDA: 202803
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
SUMATRIPTAN AND NAPROXEN SODIUM | naproxen sodium; sumatriptan succinate | TABLET;ORAL | 202803 | ANDA | NorthStar RxLLC | 16714-891 | 16714-891-01 | 9 TABLET, FILM COATED in 1 BOTTLE (16714-891-01) |
SUMATRIPTAN AND NAPROXEN SODIUM | naproxen sodium; sumatriptan succinate | TABLET;ORAL | 202803 | ANDA | Sun Pharmaceutical Industries, Inc. | 47335-410 | 47335-410-22 | 9 TABLET, FILM COATED in 1 BOTTLE (47335-410-22) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 500MG;EQ 85MG BASE | ||||
Approval Date: | Jul 20, 2018 | TE: | AB | RLD: | No |
Complete Access Available with Subscription